 VANCOUVER, BC ACCESSWIRE March 24, 2021 BetterLife Pharma Inc. BetterLife or the Company CSE:BETR OTCQB:BETRF FRA:NPAU, an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announces an agreement with the laboratory of Dr. Adam L. Halberstadt at the University of California San Diego UCSD for TD-0148A preclinical behavioural pharmacology studies. 